New Stock News | Medical solutions provider Medtronic submitted its listing application to the Hong Kong Stock Exchange for the first half of the year with a net profit of approximately 40.968 million yuan.

According to the Zhitong Financial APP, Shenzhen Maitian Bio-Medical Technology Co., Ltd. (Maitian) submitted an application for listing on the main board of the Hong Kong Stock Exchange on September 11, as disclosed by the HKEX. Morgan Stanley and Huatai International are its joint sponsors. According to the prospectus, Maitian is a global medical solutions provider with a profit of approximately 40.968 million RMB in the first half of this year.